Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	-24.41	50.19	66.40
Graham Fair Price	27.86	108668.62	84991.85
PEG	-86.07	0.23	-1.65
Price/Book	-15.21	1.25	1.48
Price/Cash Flow	-25.94	53.53	72.28
Prices/Earnings	-47.37	14.36	27.30
Price/Sales	-14.01	11.61	13.51
Price/FCF	-25.94	53.53	72.28
Naive Interpretation	member

01 - Valuation · Weak

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	-64.91	0.35	1.00
Operating Margin	8.81	0.17	0.16
ROA	62.41	0.01	< 0.005
ROE	0.01	0.02	61.11
ROIC	0.01	0.01	38.79
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.03	-0.10	70.90
Dividends QOQ	0.00	0.00	0.00
EBIT QOQ	0.07	0.08	25.21
EPS QOQ	-0.16	0.62	277.68
FCF QOQ	0.28	0.16	-45.18
Revenue QOQ	0.04	< 0.005	-88.49
Naive Interpretation	member

03 - Financial Growth · Weak

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	3158812277.49	1.06	-100.00
Days Sales Outstanding (DSO)	68.17	64.66	-5.15
Inventory Turnover	< 0.005	85.24	299180975411.39
Debt/Capitalization	0.15	0.13	-12.87
Quick Ratio	1.11	1.25	12.69
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	154076.53	155203.52	0.73
Cash	33744.92	35884.45	6.34
Capex	-731.85	-488.70	33.22
Free Cash Flow	3147.32	3629.66	15.33
Revenue	16844.44	16730.80	-0.67
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.11	1.32	17.99
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	1.15	1.37	19.25
Naive Interpretation	Member

06 - Financial Health · Weak

Rating